Greenix Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth -3.71%
- Profit Growth 15.37%
- Ebitda 54.69%
- Net Worth -60.97%
- Total Assets 170.47%
About Greenix Biotech
Greenix Biotech Private Limited (GBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 09 March 2017 (Seven years and 11 months 1 days old ). Its registered office is in Belgaum, Karnataka, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Niranjangouda Patil and Mallikarjun Sabarad serve as directors at the Company.
Company Details
-
Location
Belgaum, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01110KA2017PTC101232
-
Company No.
101232
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Mar 2017
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Greenix Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niranjangouda Patil
|
Managing Director | 09-Mar-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Mallikarjun Sabarad
|
Director | 09-Mar-2017 | Current |
Financial Performance of Greenix Biotech.
Greenix Biotech Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 3.71% decrease. The company also saw a substantial improvement in profitability, with a 15.37% increase in profit. The company's net worth observed a substantial decline by a decrease of 60.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greenix Biotech?
Unlock access to Greenix Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Greenix Biotech?
Unlock and access historical data on people associated with Greenix Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenix Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenix Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.